Difference between revisions of "Team:Valencia UPV/Achievements"

Line 50: Line 50:
 
<li>Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expected.
 
<li>Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expected.
 
<ul>
 
<ul>
−
<li>Biobrick 1, 2 and 3 are proved to work as expected.</li>
+
<li>Reporter of the recombinase PhiC31 (<a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1742008">BBa_K1742008</a>) and reporter of the recombinase Bxb1 (<a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1742006">BBa_K1742006</a>) work as expected in our project. Check it <a href="https://2015.igem.org/Team:Valencia_UPV/Components#scroll3">here</a></li>
−
<li>Biobrick 4, 5, 6 also did doing something.</li>
+
−
</ul>
+
−
</li>
+
−
<li>Document the characterization of this part in the Main Page section of the Registry entry for that Part/Device.
+
−
<ul>
+
−
<li>Check them: <a href="#">BB1</a>, <a href="#">BB2</a>, <a href="#">BB3</a>, <a href="#">BB4</a></li>
+
 
</ul>
 
</ul>
 
</li>
 
</li>
 +
 
<li>Submit this new part to the iGEM Parts <a href="http://parts.igem.org/cgi/partsdb/pgroup.cgi?pgroup=iGEM2015&group=Valencia_UPV" target="blank">Registry</a></li>
 
<li>Submit this new part to the iGEM Parts <a href="http://parts.igem.org/cgi/partsdb/pgroup.cgi?pgroup=iGEM2015&group=Valencia_UPV" target="blank">Registry</a></li>
 
<li>Demonstrate how your team has identified, investigated and addressed one or more of these issues in the context of your project (ethics, sustainability, social justice, safety, security, intellectual property rights...)
 
<li>Demonstrate how your team has identified, investigated and addressed one or more of these issues in the context of your project (ethics, sustainability, social justice, safety, security, intellectual property rights...)
 
<ul>
 
<ul>
−
<li>We studied the <a href="#">safety</a> concerns our project could have as a transgenic plant, together with the legallity of this kind of products in Europe and the need of a medical control in the case of drugs production.</li>
+
<li>We studied the <a href="https://2015.igem.org/Team:Valencia_UPV/Practices/Safety">safety</a> concerns our project could have as a transgenic plant, together with the legallity of this kind of products in Europe and the need of a medical control in the case of drugs production. </li>
 +
<li>Given the choice of drug production in our device, we decided to make it useful and important, so we researched about what drugs could be really necessary to produce in places like the Third World. Check <a href="https://2015.igem.org/Team:Valencia_UPV/Components#scroll4">here</a> our conclusions.</li>
 
</ul>
 
</ul>
 
</li>
 
</li>
Line 70: Line 66:
 
<br/>
 
<br/>
 
 
−
<span class="image left"><img style="width:6em" src="https://static.igem.org/mediawiki/2014/8/87/VUPVEdiGEM_gold_medal.png" alt="bronze medal" /></span>
+
<span class="image left"><img style="width:6em" src="https://static.igem.org/mediawiki/2014/8/87/VUPVEdiGEM_gold_medal.png" alt="gold medal" /></span>
 
<p>
 
<p>
 
<ul class="medals-tick" id="gold">
 
<ul class="medals-tick" id="gold">
Line 76: Line 72:
 
<li>Demonstrate an innovative Human Practices activity that relates to your project</li>
 
<li>Demonstrate an innovative Human Practices activity that relates to your project</li>
 
<ul>
 
<ul>
−
<li>Our team has created a <a href="#">virtual reality</a> which allows everybody to have access to a synthetic biology lab. Also, it makes possible to teach in an easy and comprehensive way what SynBio is and how it works.</li>
+
<li>Our team has created a <a href="https://2015.igem.org/Team:Valencia_UPV/Practices/Minecraft">virtual reality</a> which allows everybody to have access to a synthetic biology lab. Also, it makes possible to teach in an easy and comprehensive way what SynBio is and how it works.</li>
 
</ul>
 
</ul>
 
<li>Help a registered iGEM team from another university in a significant way by characterizing a part:  
 
<li>Help a registered iGEM team from another university in a significant way by characterizing a part:  
 
<ul>
 
<ul>
−
<li>We developed a satisfactory <a href="#">collaboration</a> with <a href="#">Norwich</a> team, by agroinfiltrating their part to test it. They also sent us their Mo-Flippers, which allows to convert our Golden Braid assemblies to BioBrick standard.</li>
+
<li>We developed a satisfactory <a href="https://2015.igem.org/Team:Valencia_UPV/Collaborations">collaboration</a> with <a href="https://2015.igem.org/Team:NRP-UEA-Norwich/Collaborations">Norwich</a> team, by testing their plant-expression constructs in our lab. They sent us their Mo-Flippers, which allow to convert our Golden Braid assemblies to BioBrick standard. Aditionally, we will be participating along with the <a href="https://2015.igem.org/Team:Cambridge-JIC">Cambrige</a> team in the plant workshop in the Jamboree!</li>
−
<li>Our team and <a href="#">Tuebingen</a> team joined forces and made a <a href="#">collaboration</a>, by making an important assembly of a CDS for them.</li>
+
<li>Our team and <a href="https://2015.igem.org/Team:Tuebingen">Tuebingen</a> team joined forces and made a modelling<a href="https://2015.igem.org/Team:Valencia_UPV/Collaborations">collaboration</a>, as they are working with the same inductor as us.</li>
−
<li>We also participated in small surveys and other <a href="#">projects</a> in order to help a bit other teams.</li>
+
<li>We also participated in small <a href="https://2015.igem.org/Team:Valencia_UPV/Collaborations">surveys</a> in order to help a bit other teams, as we consider any help given is valuable.</li>
 
</ul>
 
</ul>
 
</li>
 
</li>
−
<li>Improve the function OR characterization of a previously existing BioBrick Part or Device (created by another team, or by your own team in in a previous year of iGEM): <a href="#">BB</a></li>
+
<li>Improve the function OR characterization of a previously existing BioBrick Part or Device (created by another team, or by your own team in in a previous year of iGEM):
 +
<ul>
 +
<li>PhiC31 has been codon optimized for its use in plants <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1742004">(BBa_K1742004)</a></li>
 +
<li>ePDZ <a href="#">(BB)</a> has been tested in plants bound to AsLOV, with good results</li>
 +
</ul>
 +
</li>
 
</ul>
 
</ul>
 
</p>
 
</p>

Revision as of 22:28, 17 September 2015

Valencia UPV iGEM 2015

Medals

bronze medal

  • Register for iGEM, have a great summer, and attend the Giant Jamboree, done!
  • Complete the Judging form.
  • Description of the team's project using the iGEM wiki, and document the team's parts.
  • Present a poster and a talk at the iGEM Jamboree -we hope you like it.
  • Create a page which must clearly attribute work done by the students and distinguish it from work done by others, including host labs, advisors, instructors, sponsors, professional website designers, artists, and commercial services.
  • Document at least one new standard BioBrick Part or Device central to your project and submit this part to the iGEM Registry. You may also document a new application of a BioBrick part from a previous iGEM year: we submitted BBa_K1742002 and BBa_K1742003


bronze medal

  • Experimentally validate that at least one new BioBrick Part or Device of your own design and construction works as expected.
    • Reporter of the recombinase PhiC31 (BBa_K1742008) and reporter of the recombinase Bxb1 (BBa_K1742006) work as expected in our project. Check it here
  • Submit this new part to the iGEM Parts Registry
  • Demonstrate how your team has identified, investigated and addressed one or more of these issues in the context of your project (ethics, sustainability, social justice, safety, security, intellectual property rights...)
    • We studied the safety concerns our project could have as a transgenic plant, together with the legallity of this kind of products in Europe and the need of a medical control in the case of drugs production.
    • Given the choice of drug production in our device, we decided to make it useful and important, so we researched about what drugs could be really necessary to produce in places like the Third World. Check here our conclusions.


gold medal

  • Demonstrate an innovative Human Practices activity that relates to your project
    • Our team has created a virtual reality which allows everybody to have access to a synthetic biology lab. Also, it makes possible to teach in an easy and comprehensive way what SynBio is and how it works.
  • Help a registered iGEM team from another university in a significant way by characterizing a part:
    • We developed a satisfactory collaboration with Norwich team, by testing their plant-expression constructs in our lab. They sent us their Mo-Flippers, which allow to convert our Golden Braid assemblies to BioBrick standard. Aditionally, we will be participating along with the Cambrige team in the plant workshop in the Jamboree!
    • Our team and Tuebingen team joined forces and made a modellingcollaboration, as they are working with the same inductor as us.
    • We also participated in small surveys in order to help a bit other teams, as we consider any help given is valuable.
  • Improve the function OR characterization of a previously existing BioBrick Part or Device (created by another team, or by your own team in in a previous year of iGEM):
    • PhiC31 has been codon optimized for its use in plants (BBa_K1742004)
    • ePDZ (BB) has been tested in plants bound to AsLOV, with good results


Achievements

Text

Future perspectives

Text